Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 552 participants.
Also called NCT02617693
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 552 participants
- Sponsor
- Registry
-
NCT02617693
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Malaysia
- Registry status
- Completed
Technical summary
Registry record NCT02617693. Randomized; no masking; primary purpose prevention. Start 2015-11-23 (actual); primary completion 2017-12-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes
- Acronym
- Jom Mama
- Condition
- Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Behavioral)
- lifestyle intervention
- Intervention (Other)
- standard antenatal care
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct02617693- Content hash
2e09fb2935b4fd1783dc5f9b54648f5ceb0c30934f628eb693e264d8fa3daa39